Efficacy and safety of endoscopic submucosal dissection for gastric cancer in patients with liver cirrhosis

Kieji Ogura, M. Okamoto, T. Sugimoto, N. Yahagi, M. Fujishiro, N. Kakushima, S. Kodashima, T. Kawabe, M. Omata

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

Endoscopic submucosal dissection (ESD) has become a widely accepted method for treating gastrointestinal cancer. The aim of this study was to evaluate the efficacy and safety of ESD for gastric cancer in patients with liver cirrhosis. A total of 18 gastric cancers were treated by ESD in 15 patients with cirrhosis. The rate of en bloc resection was 88.9% (16/18). En bloc resection with tumorfree lateral/ basal margins (RO resection) was 77.8% (14/18). Three patients had postoperative bleeding and underwent emergency gastroscopy for hemostasis. No recurrence was observed during the median follow-up of 21.4 months, excluding three patients in whom additional endoscopic resection or surgery was carried out ESD can be safely performed for gastric cancer in patients with cirrhosis, resulting in a high en bloc resection rate.

Original languageEnglish
Pages (from-to)443-445
Number of pages3
JournalEndoscopy
Volume40
Issue number5
DOIs
Publication statusPublished - 2008 May 1
Externally publishedYes

ASJC Scopus subject areas

  • Gastroenterology

Fingerprint Dive into the research topics of 'Efficacy and safety of endoscopic submucosal dissection for gastric cancer in patients with liver cirrhosis'. Together they form a unique fingerprint.

  • Cite this

    Ogura, K., Okamoto, M., Sugimoto, T., Yahagi, N., Fujishiro, M., Kakushima, N., Kodashima, S., Kawabe, T., & Omata, M. (2008). Efficacy and safety of endoscopic submucosal dissection for gastric cancer in patients with liver cirrhosis. Endoscopy, 40(5), 443-445. https://doi.org/10.1055/s-2007-995650